Powder Delivery TRIZ Cases

Spray dried taurine prevents particle agglomeration and maintains stability for inhalation.

Functionalized carbon nanotubes solubilize hydrophobic drugs without toxic co-solvents, reducing side effects.

Microcrystalline cellulose carriers form spherical nicotine particles with high sphericity to improve fluidity and mouthfeel in oral pouches.

A neuregulin pharmaceutical preparation uses buffering agents to maintain pH between 3 and 7, ensuring polypeptide stability.

Sulfonated polystyrene microspheres enhance yttrium-90 adsorption strength, resolving insufficient binding in conventional radiopharmaceuticals.

Red Osier Dogwood extracts rich in rutin and quercetin replace silage to promote animal growth while reducing antibiotic dependency.

Acrylic silicone copolymer with hydrolyzable silyl groups bonds to cosmetic powders to block surface activity and enhance water resistance.

Aprotic polar solvent solubilizes dried insulin into stable monomeric forms, resolving the trade-off between stability and absorption rate.

O-acetylated beta-1,6-glucan enhances phagocytosis and reactive oxygen species production to resolve insufficient anti-infective activity in immunotherapy.

Hyaluronidase degrades hyaluronic acid in the formulation to reduce viscosity, enabling higher therapeutic doses for subcutaneous injection.

Lyophilized Fab-PEG formulations resolve aggregation and reconstitution delays through optimized sucrose and glycine buffers.

Ang-2 polypeptide modification directs the nanocomposite across the blood-brain barrier to treat brain tumors while enhancing near-infrared light absorption.

A nasal spray composition containing hemp oil, sesame oil, and crystalline cannabidiol for intranasal delivery.

Bronchial airway gene expression profiling predicts lung function decline rates to enable early intervention before substantial respiratory damage occurs.

Micelle-encapsulated phthalocyanine dyes accumulate in tumors, enabling endoscopic visualization without complex imaging equipment.

Bioorthogonal compositions use selective functional group binding to attach therapeutic payloads to implanted supports for controlled release.

CXCR4-targeted nanoparticles resolve the toxicity-efficacy trade-off by delivering sorafenib directly to liver cancer cells, reducing systemic side effects.

Optimized 13-90 nm globular chelating polymeric nanostructures resolve tumor delivery efficiency and radioisotope loading capacity trade-offs.

Radial gas flow cools knives and transports granules, preventing clumping and clogging at high throughput rates.

Ultramicronized endocannabinoids in lipid complexes increase dispersibility and bioavailability, resolving insufficient absorption in conventional formulations.

Oxidize polysaccharides to aldehyde groups for covalent bonding with hydrophobic agents.

Polymer particles balance stability and compressibility to deliver therapeutic agents while maintaining structural integrity during vascular occlusion.

Sulfur-containing microparticles deliver cysteamine to lung tissues via sustained release mechanisms.

Crystalline maltitol powder maintains flowability through controlled moisture balance and surface stabilization during drying.

Cold air spraying of molten reduced coenzyme Q10 lowers crystallinity, improving oral bioavailability and stability without toxic solvent residues.

Thermal curing at 125 to 160 degrees Celsius prevents agglomeration and amorphous formation in micronized glycopyrronium bromide.

A clinoptilolite zeolite preparation adsorbs alcohol molecules to reduce systemic absorption.

Engineered mesoscale pores selectively bind cholesterol to lower levels without systemic side effects.

Targeting HSPG2 with scFv antibody fragments detects rare circulating tumor cells with an epithelial-to-mesenchymal transition phenotype.

Propellant evaporation drives topical formulations toward supersaturation to enhance drug flux across the skin.

AS1411 oligonucleotide composite ruthenium complex nanoprobe resolves membrane penetration efficiency trade-offs while maintaining tumor targeting specificity.

Non-ordered inorganic oxide materials enhance biologically active material dissolution rates through controlled pore structures.

Polymer-coated potassium iodide nanoparticles extend circulation half-life and improve tumor retention for enhanced radiotherapy efficacy.

Targeting the upper nasal passage enables cannabidiol to bypass systemic metabolism and cross the blood-brain barrier, resolving poor brain bioavailability.

Polyethylene glycol polymers with silane groups coat magnetic nanoparticles, extending circulation time and reducing immunogenicity.

Neuromodulation agents in sucrose solutions stimulate mosquito feeding behavior, resolving insufficient engorgement that hinders pathogen detection reliability.

Biodegradable nanocomposites use supercritical carbon dioxide processing to achieve uniform reinforcing agent dispersion.

A cationic amphipathic polymer complex facilitates nucleic acid transfection into target cells.

Nanoparticles convert ionizing radiation into localized light to activate photosensitizers and generate cytotoxic singlet oxygen species.

A porous bone graft scaffold uses freeze-dried binding agents to maintain structural integrity for surgical handling.

Microbial composition combining Lactobacillus and Bacillus strains reduces APEC levels and mortality while establishing stable gut microbiome homeostasis.

A lipid-coated mesoporous silica nanoparticle encapsulates CRISPR-Cas9 cargo within its internal pores to facilitate cellular uptake.

CAQK peptides bind chondroitin sulfate proteoglycans to deliver systemically administered therapeutic agents across the blood-brain barrier.

Release rate-controlling polymer films modulate memantine diffusion through flexible shells, maintaining stable serum plasma levels over four to ten days.

Topical TNF-alpha antibodies resolve GI inflammation without systemic immunosuppression, preserving cancer therapy continuity.

Polymerized siRNA nanocapsules cross the blood-brain barrier to achieve effective gene silencing in glioblastoma models.

High-density nanoparticle gel improves tumor bed delineation accuracy by 40%, reducing inter-observer variability and optimizing radiation dose delivery.

Composite lipid formulations lower triglycerides and cholesterol without combination therapy side effects.

Multiblock copolymers self-assemble into micelles to encapsulate hydrophobic drugs in aqueous solutions.

Segmenting the delivery system into distinct functional components directs drugs to target neurons, reducing systemic side effects.